| J9271 | Injection, pembrolizumab, 1 mg | 7,600 | $40 | $326.8K |
| J0897 | Injection, denosumab, 1 mg | 7,200 | $20 | $129.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $90 | $63.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $100 | $28.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 390 | $60 | $23.2K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 130 | $90 | $11.3K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1,870 | $10 | $11.2K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 20 | $340 | $7.8K |
| 99221 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a straightforward or low level of medical… | 80 | $60 | $5.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $120 | $4.9K |